Based on the clinical manifestations, the brain MRI findings, and CSF levels of Aβ42, P-tau, and T-tau, the patient was diagnosed as having AD with parkinsonian features (Fig. 1A, 1C). The gene discussed is MAPT; the disease is Alzheimer disease.